FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds intended for treatment of hepatitis C of formula
:
its stereoisomeric forms, pharmaceutically acceptable salts or solvates, where R1 represents hydrogen; R2 represents hydrogen, napthyl or phenyl, optionally substituted with 1, 2 or 3 substituents, selected from halogen and C1-C6alkyl; R3 and R4 represent hydrogen or C1-C6alkyl; R5 represents C1-C10alkyl, optionally substituted with C1-C6alkoxygroup, C3-C7cycloalkyl or benzyl; R8 represents hydrogen.
EFFECT: claimed are novel compounds and composition on their base, effective against hepatitis C.
12 cl, 4 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DIARYL ETHERS | 2010 |
|
RU2528231C2 |
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | 2007 |
|
RU2525392C2 |
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | 2007 |
|
RU2466729C2 |
MACROCYCLIC INDOLE DERIVATIVES, APPLICABLE AS INHIBITORS OF HEPATITIS C VIRUS | 2009 |
|
RU2518471C2 |
PHENYLETHYNYL DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2538507C2 |
PESTICIDE COMPOSITIONS | 2010 |
|
RU2550352C2 |
NUCLEOSIDE ARYL PHOSPHORAMIDATES AND USE THEREOF AS ANTI-VIRAL AGENTS FOR TREATING HEPATITUS C VIRUS | 2007 |
|
RU2464272C2 |
BRIDGED N-CYCLYC SULPHONAMIDO-INHIBITORS OF GAMMA-SECRETASE | 2006 |
|
RU2422443C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE 1β-ADRENERGIC RECEPTOR INHIBITORS | 2006 |
|
RU2415855C2 |
COMPOUNDS OF SUBSTITUTED PYRAZOLE CONTAINING PYRIMIDINYL, PRODUCTION AND USE THEREOF | 2016 |
|
RU2687089C2 |
Authors
Dates
2015-06-20—Published
2010-09-29—Filed